Financials
- Market Capitalization 2.52 B
- Employee 1 797
- Founded 2013
- CEO N/A
- Website www.zailaboratory.com
- Headquarter Cayman Islands
- FIGI BBG00HFX3N90
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-110.25
ratio cours/chiffre d'affaires
41.99
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1722 | PGEN Precigen, Inc. - Common Stock | 7.35 USD | -1.74% | -2.52% | +7.93% | +128.26% | 2.63 B USD | ||
| 1745 | NRIX Nurix Therapeutics, Inc. - Common stock | 23.66 USD | +6.91% | +4.09% | -7.11% | +111.06% | 2.58 B USD | ||
| 1789 | BEAM Beam Therapeutics Inc. - Common Stock | 23.65 USD | -3.19% | -4.52% | -0.71% | -7.83% | 2.44 B USD | ||
| 1795 | SLS SELLAS Life Sciences Group, Inc. - Common Stock | 11.89 USD | -4.19% | +5.13% | +3.03% | +455.61% | 2.40 B USD |